Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Capital Work in Progress

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹137 Cr₹64 Cr₹130 Cr₹223 Cr₹518 Cr

What is the latest Capital Work in Progress ratio of NATCO PHARMA ?

The latest Capital Work in Progress ratio of NATCO PHARMA is ₹137 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹137 Cr
Mar2023₹64 Cr
Mar2022₹130 Cr
Mar2021₹223 Cr
Mar2020₹518 Cr

How is Capital Work in Progress of NATCO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹137 Cr
113.53
Mar2023 ₹64 Cr
-50.35
Mar2022 ₹130 Cr
-42.03
Mar2021 ₹223 Cr
-56.87
Mar2020 ₹518 Cr -

Compare Capital Work in Progress of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,567.1 Cr -4.4% 0.9% -17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,406.0 Cr -2.7% 3.9% 19.8% Stock Analytics
DIVIS LABORATORIES ₹163,113.0 Cr 1% 8.5% 55.3% Stock Analytics
CIPLA ₹121,869.0 Cr -2.6% 3.9% 6.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,345.0 Cr -0.7% 2.5% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,801.0 Cr -1.9% 0.9% -7.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-4.4%

0.9%

-17.9%

SENSEX

0.6%

6.2%

8.4%


You may also like the below Video Courses